Results 91 to 100 of about 100,711 (219)

Paradoxical Movement of Vocal Cords in Guillain - Barré Syndrome: Report a Case and Review of the Literature

open access: yesSiriraj Medical Journal, 2007
This is a report of a 50 year-old Thai male who was admitted to Siriraj Hospital because of progressive weakness of all extremities and increase shortness of breath. Endotracheal tube intubation was introduced for ventilatory support and secretion clearance.
Thanet Chaisathaphol, Jamsak Tscheikuna
openaire   +1 more source

An unusual presentation of gbs: case report and literature review [PDF]

open access: yes, 2016
Guillain-Barre syndrome (GBS), also known as Landry paralysis is an acute idiopathic polyneuritis, believed to be immunologically mediated. It usually presents as a demyelinating neuropathy with ascending weakness, however, many clinical variants have ...
Badshah, Mazhar   +3 more
core   +1 more source

Vaccines in Current Culture: The HPV Vaccine Controversy [PDF]

open access: yes, 2020
The use of vaccinations has drastically decreased mortality and morbidity rates related to infectious disease and has become an intrinsic part of modern health care.
Johnston, Alyssa
core   +1 more source

Regional variation of Guillain-Barré syndrome

open access: yesBrain : a journal of neurology, 2018
Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation, electrophysiological subtype and outcome. Previous single country reports indicate that Guillain-Barré syndrome may differ among regions, but no systematic ...
A. Y. Doets   +43 more
semanticscholar   +1 more source

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

open access: yesCancer Science, EarlyView.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada   +9 more
wiley   +1 more source

A rapid onset of Guillain–Barre syndrome following spinal anesthesia for knee arthroscopy: a case report

open access: yesJournal of Medical Case Reports
Background Guillain–Barré syndrome, a rare autoimmune polyneuropathy, typically follows infections and rarely surgical procedures. Post-surgical Guillain–Barré syndrome is an uncommon subset with significant clinical implications.
Amin Ahmed Kapadia   +4 more
doaj   +1 more source

High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome [PDF]

open access: yesVojnosanitetski Pregled, 2006
Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases.
Lavrnić Dragana   +9 more
doaj   +1 more source

Guillain-Barré Syndrome in Pediatric Age - Management Guidelines [PDF]

open access: yes, 2011
O protocolo de actuação na Síndrome de Guillain-Barré em idade pediátrica foi elaborado com o intuito de rever as mais recentes recomendações internacionais e de traçar linhas orientadoras de actuação.
Figueiroa, S   +5 more
core  

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals [PDF]

open access: yes, 2011
Objectives:  Anti-ganglioside antibodies are present in approximately half of Guillain–Barré syndrome (GBS) patients. Recently, it has been shown that a considerable proportion of these patients has serum antibodies against antigenic epitopes formed by a
Goodfellow   +22 more
core   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

open access: yesCancer Science, EarlyView.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy